Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

Been awhile, but have to respond to this one...., "no market for a AD diagnostic?" Eli spent $800M for AMVID, a AD diagnostic product..Are you suggesting they did this for a product with "no market."

And that's $800M for a POS that even states on the disclosures that "A positive Amyvid scan does not establish a diagnosis of AD or other cognitive disorder.”